JP Stock MarketDetailed Quotes

2929 Pharma Foods International

Watchlist
  • 985
  • +33+3.47%
20min DelayMarket Closed Nov 29 15:30 JST
28.64BMarket Cap8.74P/E (Static)

Pharma Foods International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
Total revenue
-9.37%62.15B
-6.63%14.98B
-10.76%15.52B
-14.37%15.51B
-5.21%16.14B
13.94%68.57B
-0.59%16.04B
14.19%17.39B
11.71%18.11B
35.09%17.03B
Cost of revenue
0.77%13.4B
15.00%3.53B
-4.41%3.32B
-11.97%3.13B
6.87%3.42B
10.07%13.29B
-5.63%3.07B
14.10%3.47B
-8.17%3.55B
67.05%3.2B
Gross profit
-11.81%48.75B
-11.74%11.45B
-12.36%12.2B
-14.95%12.38B
-8.01%12.72B
14.91%55.28B
0.68%12.97B
14.22%13.92B
17.92%14.56B
29.36%13.83B
Operating expense
-15.55%43.64B
-12.69%9.6B
-8.17%10.47B
-13.59%11.45B
-24.37%12.11B
9.87%51.67B
-13.66%11B
-14.21%11.4B
11.45%13.25B
75.83%16.02B
Selling and administrative expenses
-18.55%34.99B
-15.41%7.42B
-9.85%8.42B
-16.46%9.21B
-28.11%9.94B
9.71%42.96B
-16.73%8.77B
-18.03%9.34B
13.13%11.03B
84.75%13.82B
-Selling and marketing expense
-20.78%30.79B
-17.24%6.39B
-10.86%7.41B
-18.52%8.18B
-31.15%8.81B
8.72%38.87B
-19.49%7.72B
-21.20%8.31B
12.96%10.04B
90.19%12.8B
-General and administrative expense
2.61%4.2B
-1.99%1.03B
-1.74%1.01B
4.33%1.04B
10.11%1.12B
20.05%4.1B
11.19%1.05B
21.13%1.03B
14.95%992M
35.87%1.02B
Research and development costs
16.43%978M
13.28%273M
19.89%223M
-0.97%205M
34.47%277M
9.66%840M
-17.18%241M
12.73%186M
25.45%207M
42.07%206M
Depreciation and amortization
37.50%99M
0.00%18M
0.00%18M
110.53%40M
35.29%23M
41.18%72M
5.88%18M
38.46%18M
72.73%19M
70.00%17M
-Depreciation
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Amortization
37.50%99M
0.00%18M
0.00%18M
110.53%40M
35.29%23M
41.18%72M
5.88%18M
38.46%18M
72.73%19M
70.00%17M
Other operating expenses
-2.90%7.57B
-3.87%1.89B
-2.59%1.81B
-0.25%1.99B
-4.91%1.88B
10.57%7.79B
3.80%1.97B
8.23%1.86B
1.58%2B
33.97%1.98B
Operating profit
41.64%5.12B
-6.43%1.85B
-31.31%1.73B
-28.70%934M
127.50%603M
233.83%3.61B
1,234.46%1.98B
328.88%2.52B
186.03%1.31B
-239.06%-2.19B
Net non-operating interest income (expenses)
-29.79%-61M
-63.64%-18M
-23.08%-16M
-18.18%-13M
-16.67%-14M
-95.83%-47M
-57.14%-11M
-160.00%-13M
-10.00%-11M
-500.00%-12M
Non-operating interest income
0.00%1M
--0
0.00%1M
--0
--0
-50.00%1M
--0
--1M
-700.00%-6M
--6M
Non-operating interest expense
29.17%62M
63.64%18M
21.43%17M
160.00%13M
-22.22%14M
84.62%48M
37.50%11M
180.00%14M
-54.55%5M
800.00%18M
Net investment income
-5.88%32M
-58.33%10M
266.67%5M
1,000.00%11M
-50.00%6M
-53.42%34M
20.00%24M
-110.00%-3M
-93.75%1M
71.43%12M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
-90.63%-122M
-140.74%-130M
10M
0
-2M
-6,300.00%-64M
-5,300.00%-54M
0
-10M
0
Income from associates and other participating interests
57.32%-35M
66.67%-7M
-21.74%-28M
103.85%1M
91.67%-1M
-1,740.00%-82M
-200.00%-21M
-483.33%-23M
-620.00%-26M
-1,300.00%-12M
Special income (charges)
-5,150.00%-101M
-101M
-98.74%2M
0
Less:Other special charges
5,150.00%101M
----
----
----
----
97.40%-2M
--0
----
----
----
Other non-operating income (expenses)
133.71%208M
387.80%200M
-157.89%-11M
100.00%6M
-50.00%13M
-31.01%89M
20.59%41M
-53.66%19M
-85.00%3M
-23.53%26M
Income before tax
42.12%5.03B
-8.07%1.8B
-32.21%1.69B
-26.10%937M
127.75%605M
148.91%3.54B
638.87%1.96B
342.80%2.5B
160.37%1.27B
-228.31%-2.18B
Income tax
295.67%1.83B
935.19%451M
17.54%603M
25.97%456M
188.58%318M
-74.29%462M
-115.21%-54M
-37.21%513M
129.11%362M
-176.87%-359M
Net income
4.06%3.21B
-32.99%1.35B
-45.11%1.09B
-46.74%482M
115.71%286M
923.53%3.08B
2,336.67%2.01B
207.43%1.98B
174.24%905M
-247.85%-1.82B
Net income continuous operations
4.09%3.21B
-32.95%1.35B
-45.08%1.09B
-46.91%481M
115.76%287M
923.53%3.08B
2,335.56%2.01B
207.48%1.98B
175.38%906M
-247.81%-1.82B
Noncontrolling interests
0
0
0
0
0
0
0
1M
-1M
0
Net income attributable to the company
4.02%3.21B
-32.99%1.35B
-45.11%1.09B
-46.80%482M
115.71%286M
923.80%3.08B
2,336.67%2.01B
207.43%1.98B
174.55%906M
-247.85%-1.82B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
4.02%3.21B
-32.99%1.35B
-45.11%1.09B
-46.80%482M
115.71%286M
923.80%3.08B
2,336.67%2.01B
207.43%1.98B
174.55%906M
-247.85%-1.82B
Gross dividend payment
Basic earnings per share
5.63%112.71
-31.55%47.71
-44.16%38.32
-46.28%16.74
115.83%9.94
927.77%106.7
2,348.39%69.7
207.81%68.62
173.09%31.16
-247.89%-62.78
Diluted earnings per share
5.63%112.71
-31.55%47.71
-44.16%38.32
-46.28%16.74
115.83%9.94
927.77%106.7
2,347.54%69.7
207.73%68.62
173.09%31.16
-247.96%-62.78
Dividend per share
13.64%25
25.00%15
0
0.00%10
0
10.00%22
20.00%12
0
0.00%10
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Jul 31, 2024 (Q4)Jul 31, 2024 (Q3)Apr 30, 2024 (Q2)Jan 31, 2024 (Q1)Oct 31, 2023 (FY)Jul 31, 2023 (Q4)Jul 31, 2023 (Q3)Apr 30, 2023 (Q2)Jan 31, 2023 (Q1)Oct 31, 2022
Total revenue -9.37%62.15B -6.63%14.98B -10.76%15.52B -14.37%15.51B -5.21%16.14B 13.94%68.57B -0.59%16.04B 14.19%17.39B 11.71%18.11B 35.09%17.03B
Cost of revenue 0.77%13.4B 15.00%3.53B -4.41%3.32B -11.97%3.13B 6.87%3.42B 10.07%13.29B -5.63%3.07B 14.10%3.47B -8.17%3.55B 67.05%3.2B
Gross profit -11.81%48.75B -11.74%11.45B -12.36%12.2B -14.95%12.38B -8.01%12.72B 14.91%55.28B 0.68%12.97B 14.22%13.92B 17.92%14.56B 29.36%13.83B
Operating expense -15.55%43.64B -12.69%9.6B -8.17%10.47B -13.59%11.45B -24.37%12.11B 9.87%51.67B -13.66%11B -14.21%11.4B 11.45%13.25B 75.83%16.02B
Selling and administrative expenses -18.55%34.99B -15.41%7.42B -9.85%8.42B -16.46%9.21B -28.11%9.94B 9.71%42.96B -16.73%8.77B -18.03%9.34B 13.13%11.03B 84.75%13.82B
-Selling and marketing expense -20.78%30.79B -17.24%6.39B -10.86%7.41B -18.52%8.18B -31.15%8.81B 8.72%38.87B -19.49%7.72B -21.20%8.31B 12.96%10.04B 90.19%12.8B
-General and administrative expense 2.61%4.2B -1.99%1.03B -1.74%1.01B 4.33%1.04B 10.11%1.12B 20.05%4.1B 11.19%1.05B 21.13%1.03B 14.95%992M 35.87%1.02B
Research and development costs 16.43%978M 13.28%273M 19.89%223M -0.97%205M 34.47%277M 9.66%840M -17.18%241M 12.73%186M 25.45%207M 42.07%206M
Depreciation and amortization 37.50%99M 0.00%18M 0.00%18M 110.53%40M 35.29%23M 41.18%72M 5.88%18M 38.46%18M 72.73%19M 70.00%17M
-Depreciation --0 --0 --0 --0 --0 --0 --0 --0 --0 --0
-Amortization 37.50%99M 0.00%18M 0.00%18M 110.53%40M 35.29%23M 41.18%72M 5.88%18M 38.46%18M 72.73%19M 70.00%17M
Other operating expenses -2.90%7.57B -3.87%1.89B -2.59%1.81B -0.25%1.99B -4.91%1.88B 10.57%7.79B 3.80%1.97B 8.23%1.86B 1.58%2B 33.97%1.98B
Operating profit 41.64%5.12B -6.43%1.85B -31.31%1.73B -28.70%934M 127.50%603M 233.83%3.61B 1,234.46%1.98B 328.88%2.52B 186.03%1.31B -239.06%-2.19B
Net non-operating interest income (expenses) -29.79%-61M -63.64%-18M -23.08%-16M -18.18%-13M -16.67%-14M -95.83%-47M -57.14%-11M -160.00%-13M -10.00%-11M -500.00%-12M
Non-operating interest income 0.00%1M --0 0.00%1M --0 --0 -50.00%1M --0 --1M -700.00%-6M --6M
Non-operating interest expense 29.17%62M 63.64%18M 21.43%17M 160.00%13M -22.22%14M 84.62%48M 37.50%11M 180.00%14M -54.55%5M 800.00%18M
Net investment income -5.88%32M -58.33%10M 266.67%5M 1,000.00%11M -50.00%6M -53.42%34M 20.00%24M -110.00%-3M -93.75%1M 71.43%12M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets -90.63%-122M -140.74%-130M 10M 0 -2M -6,300.00%-64M -5,300.00%-54M 0 -10M 0
Income from associates and other participating interests 57.32%-35M 66.67%-7M -21.74%-28M 103.85%1M 91.67%-1M -1,740.00%-82M -200.00%-21M -483.33%-23M -620.00%-26M -1,300.00%-12M
Special income (charges) -5,150.00%-101M -101M -98.74%2M 0
Less:Other special charges 5,150.00%101M ---- ---- ---- ---- 97.40%-2M --0 ---- ---- ----
Other non-operating income (expenses) 133.71%208M 387.80%200M -157.89%-11M 100.00%6M -50.00%13M -31.01%89M 20.59%41M -53.66%19M -85.00%3M -23.53%26M
Income before tax 42.12%5.03B -8.07%1.8B -32.21%1.69B -26.10%937M 127.75%605M 148.91%3.54B 638.87%1.96B 342.80%2.5B 160.37%1.27B -228.31%-2.18B
Income tax 295.67%1.83B 935.19%451M 17.54%603M 25.97%456M 188.58%318M -74.29%462M -115.21%-54M -37.21%513M 129.11%362M -176.87%-359M
Net income 4.06%3.21B -32.99%1.35B -45.11%1.09B -46.74%482M 115.71%286M 923.53%3.08B 2,336.67%2.01B 207.43%1.98B 174.24%905M -247.85%-1.82B
Net income continuous operations 4.09%3.21B -32.95%1.35B -45.08%1.09B -46.91%481M 115.76%287M 923.53%3.08B 2,335.56%2.01B 207.48%1.98B 175.38%906M -247.81%-1.82B
Noncontrolling interests 0 0 0 0 0 0 0 1M -1M 0
Net income attributable to the company 4.02%3.21B -32.99%1.35B -45.11%1.09B -46.80%482M 115.71%286M 923.80%3.08B 2,336.67%2.01B 207.43%1.98B 174.55%906M -247.85%-1.82B
Preferred stock dividends
Other under preferred stock dividend 0 0 0 0 0 0 0 0 0 0
Net income attributable to common stockholders 4.02%3.21B -32.99%1.35B -45.11%1.09B -46.80%482M 115.71%286M 923.80%3.08B 2,336.67%2.01B 207.43%1.98B 174.55%906M -247.85%-1.82B
Gross dividend payment
Basic earnings per share 5.63%112.71 -31.55%47.71 -44.16%38.32 -46.28%16.74 115.83%9.94 927.77%106.7 2,348.39%69.7 207.81%68.62 173.09%31.16 -247.89%-62.78
Diluted earnings per share 5.63%112.71 -31.55%47.71 -44.16%38.32 -46.28%16.74 115.83%9.94 927.77%106.7 2,347.54%69.7 207.73%68.62 173.09%31.16 -247.96%-62.78
Dividend per share 13.64%25 25.00%15 0 0.00%10 0 10.00%22 20.00%12 0 0.00%10 0
Currency Unit JPY JPY JPY JPY JPY JPY JPY JPY JPY JPY
Accounting Standards NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data